Vitamin D Deficiency in Asian-American Patients with Chronic Hepatitis B in New York Downtown Hospital
L. Mi1; L. A. Rincon-Bejarano1; R. Babbar1;E. K. Chiu1; M. Martell1; J. Karsdon2; M. G.Ghany 3
1. Medicine, New York Downtown Hospital, New York, NY, United States.
2. Pediatrics/Neonatology, New York Downtown Hospital,New York, NY, United States.
3. Liver Disease Branch/NIDDK, National Institutes of Health, Bethesda, MD, United States.
Background: Vitamin D production is related to liver function. Vitamin D levels have been shown to be associated with disease severity in a variety of liver conditions including autoimmune hepatitis and hepatitis C. Moreover, levels have been shown to improve following antiviral treatment in chronic hepatitis C. There have been limited reports on vitamin D levels in Asian patients with chronic hepatitis B (CHB).
Aims: to determine if 1) there is a difference in vitamin D levels and deficiency in Asian-American outpatients with and without CHB in a New York downtown area,and 2) whether antiviral treatment affects vitamin D levels.
Method: Of 118 outpatients attending New York Downtown Hospital between November 4, 2010through May 30, 2011, 62 were Chinese-American patients, 25 of whom had CHB.Vitamin D3, ALT and HBV DNA levels were measured in all patients. Means were compared by Student t-test.
Results: See Table 1: Patients with CHB were significantly younger compared to those without CHB (58 vs 40 years). Among those with CHB, only 2 had cirrhosis and 10 were being treated with either entecavir (n=4) or tenofovir (n=6). There was no difference in the mean vitamin D level (ng/ml) between Asian patients with and without CHB (22.84+/-10.8 vs 23.27+/-9.27) (p=ns). Mean vitamin D levels were not significantly different in CHB patients on treatment (22.64) compared to those not on treatment (19.33) However, the rate of vitamin D deficiency (defined as a level <30mg/ml) was slightly higher in the CHB patients (40%) than in the non-CHB patients (32%) (p=ns).
Discussion: Unlike hepatitis C, Asian CHB patients without cirrhosis did notseem to have a significant higher rate of vitamin D deficiency compared tothose without CHB.
Table 1. Serum 25-OH vitamin D3 levels in Asian-American outpatients with orwithout CHB.
| Total | Non-CHB | CHB | P values |
# of patients | 62 | 37 | 25 |
|
Age (mean+/-sd) | 50.8 +/- 18.5 | 58.16+/- 17.1 | 40.0+/- 15.4 | 0.0003 |
Vit D (ng/ml) | 23.1+/- 9.82 | 23.27+/- 9.27 | 22.84+/- 12.8 | 0.8673 |
# of normal vit D (%) | 13 (21%) | 9 (24%) | 4 (16%) | 0.436 |
# of vit D insufficiency (%) | 27 (44%) | 16 (43%) | 11 (44%) | 0.938 |
# of vit D deficiency (%) | 22 (35%) | 12 (32) | 10 (40%) | 0.5228 |
欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |